Vimarsana
Biggest News Aggregation in the World

Page 33 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

New diagnostic tool could revolutionize early bladder cancer detection - Vimarsana News

New diagnostic tool could revolutionize early bladder cancer detection

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages.

Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript - Vimarsana News

Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript August 10, 2023 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.24. Operator: Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask […]

Source: yahoo.com
Soft summer season hits healthcare service providers - Vimarsana News

Soft summer season hits healthcare service providers

Fortis and Max Institute reported subdued sequential revenue growth in the June 2023 quarter

Tumor's consistency can have a decisive influence on cancer progression - Vimarsana News

Tumor's consistency can have a decisive influence on cancer progression

Doctors have been palpating suspicious hardened areas under their patients' skin throughout recorded history.

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines - Vimarsana News

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.